| Filed On | Filing |
|---|---|
| 30 Sep 2025 |
8-K/A: Financial Statements and Exhibits
We have audited the financial statements of Melinta Therapeutics, LLC and Subsidiaries (the “Company”), which comprise the consolidated balance sheets as of December 31, 2024 and 2023, and the related consolidated statements of operation... |
| 09 Aug 2017 | 8-K/A: Submission of Matters to a Vote of Security Holders |
| 09 Feb 2015 | 8-K/A: Financial Statements and Exhibits |
| 28 May 2014 | 8-K/A: Notice of Delisting or Failure to Satisfy a Listing Rule |
Loading...
